Effectiveness of 0.01% atropine in anisomyopic children

Effectiveness of 0.01% atropine in anisomyopic children

Purpose: To investigate the change in ocular parameters of anisomyopic children treated with 0.01% atropine. Methods: This retrospective study analyzed the data of anisomyopic children who underwent comprehensive examination at a tertiary eye center in India. Anisomyopic subjects (difference of ≥1...

Full description

Bibliographic Details
Main Authors:	Azfira Hussain, Aparna Gopalakrishnan, Saurav Chowdhury, Sumita Agarkar
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Indian Journal of Ophthalmology
Subjects:	0.01% atropine anisomyopia axial length myopia spherical equivalent
Online Access:	http://www.ijo.in/article.asp?issn=0301-4738;year=2023;volume=71;issue=5;spage=2109;epage=2114;aulast=Hussain

Similar Items

Effect of orthokeratology combined with 0.01% atropine solution on adolescents with myopia
by: Ying Liu, et al.
Published: (2023-08-01)

Is 0.01% Atropine an Effective and Safe Treatment for Myopic Children? A Systemic Review and Meta-Analysis
by: Hou-Ren Tsai, et al.
Published: (2021-08-01)

Efficacy of 0.01% atropine in myopic children of different ages
by: Lan Hu, et al.
Published: (2023-03-01)

Effect of 0.01% atropine combined with orthokeratology lens on axial elongation: a 2-year randomized, double-masked, placebo-controlled, cross-over trial
by: Binbin Li, et al.
Published: (2024-04-01)

Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial
by: Shiao Yu, et al.
Published: (2022-11-01)

Efficacy of topical low-dose atropine eye drops (0.01%) in slowing myopia progression in school-age children
by: Yashi Bansal, et al.
Published: (2024-01-01)

Role of 0.01% atropine in high myopic children of Moradabad, India (RAMCOM Study)
by: Pradeep Agarwal, et al.
Published: (2022-01-01)

Meta-analysis of 0.01% Atropine for Asian adolescents and children of low and medium myopia in diopter and axial length
by: Hao-Bo Fan, et al.
Published: (2021-05-01)

Short-term effect of 0.01% atropine sulphate eye gel on myopia progression in children
by: Shi-Yin Pan, et al.
Published: (2022-07-01)

Two-Year Results of 0.01% Atropine Eye Drops and 0.1% Loading Dose for Myopia Progression Reduction in Danish Children: A Placebo-Controlled, Randomized Clinical Trial
by: Niklas Cyril Hansen, et al.
Published: (2024-02-01)

Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trial
by: Ying Yuan, et al.
Published: (2021-12-01)

Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety
by: Niklas Cyril Hansen, et al.
Published: (2023-10-01)

Retinal image quality in myopic children undergoing orthokeratology alone or combined with 0.01% atropine
by: Qi Tan, et al.
Published: (2023-06-01)

The Effect of 0.01% Atropine Eye Drops on the Ocular Surface in Children for the Control of Myopia—The Primary Results from a Six-Month Prospective Study
by: Cheng J, et al.
Published: (2020-08-01)

0.05% atropine on control of myopia progression in Chinese school children: a randomized 3-year clinical trial
by: Qin Zhu, et al.
Published: (2023-06-01)

Effect of 0.01% atropine eyedrops on intraocular pressure in schoolchildren: a randomized clinical trial
by: Javaria Bukhari, et al.
Published: (2022-09-01)

Myopia Control with Low-Dose Atropine in European Children: Six-Month Results from a Randomized, Double-Masked, Placebo-Controlled, Multicenter Study
by: Anders Hvid-Hansen, et al.
Published: (2023-02-01)

The Effect of Long-Term Low-Dose Atropine on Refractive Progression in Myopic Australian School Children
by: William Myles, et al.
Published: (2021-04-01)

Add-On Effect of 0.01% Atropine in Orthokeratology Wearers for Myopia Control in Children: A 2-Year Retrospective Study
by: Linlin Du, et al.
Published: (2023-07-01)

Low-Dose Atropine Induces Changes in Ocular Biometrics in Myopic Children: Exploring Temporal Changes by Linear Mixed Models and Contribution to Treatment Effect by Mediation Analyses
by: Anders Hvid-Hansen, et al.
Published: (2023-02-01)

Topical atropine in retarding myopia progression and axial length growth in children with myopia
by: Abdur Rahman Mohammad Alam, et al.
Published: (2020-12-01)

Effects of atropine 0.01% on refractive errors in children with myopia
by: Xingxue Zhu, et al.
Published: (2023-08-01)

The Effects of 0.01% Atropine on Adult Myopes’ Contrast Sensitivity
by: Ziyun Cheng, et al.
Published: (2021-02-01)

The Effect of Myopic Control between the Dual-Focus Contact Lenses and High-Concentration Atropine in an Asian Population
by: Chia-Yi Lee, et al.
Published: (2024-01-01)

Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control
by: Xiaoyu Zhang, et al.
Published: (2020-09-01)

Effect of orthokeratology on anisometropia control: A meta-analysis
by: Hou-Ren Tsai, et al.
Published: (2021-12-01)

A Pilot Study on the Efficacy and Safety of 0.01% Atropine in German Schoolchildren with Progressive Myopia
by: Lutz Joachimsen, et al.
Published: (2019-06-01)

Effect of 0.02% and 0.01% atropine on astigmatism: a two-year clinical trial
by: Ming Wang, et al.
Published: (2022-04-01)

Treatment of Myopia with Atropine 0.125% Once Every Night Compared with Atropine 0.125% Every Other Night: A Pilot Study
by: Zi-Rong Chen, et al.
Published: (2023-08-01)

Effect of atropine 0.01% on myopia control in children aged 6–13 years during the 2022 lockdown in Shanghai
by: Manrong Yu, et al.
Published: (2023-01-01)

Observation of the effect of posterior scleral reinforcement combined with orthokeratology and 0.01% atropine in the treatment of congenital myopia: a case report
by: Chunxiao Yan, et al.
Published: (2023-11-01)

Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: A systematic review and network meta-analysis
by: Hou-Ren Tsai, et al.
Published: (2022-12-01)

Convergence excess consecutive esotropia associated with 0.01% atropine eye drops usage in patients operated for intermittent exotropia
by: Mihir Kothari, et al.
Published: (2020-01-01)

Effect of 0.02% and 0.01% atropine on ocular biometrics: A two-year clinical trial
by: Ming Wang, et al.
Published: (2023-01-01)

The Role of Atropine in Preventing Myopia Progression: An Update
by: Alberto Chierigo, et al.
Published: (2022-04-01)

Atropine in the treatment of childhood myopia
by: Sanitha Sathyan
Published: (2019-01-01)

Consensus statement and guidelines for use of dilute atropine sulphate in myopia control
by: Siddharth S Kesarwani, et al.
Published: (2019-01-01)

The accuracy of the axial length and axial length/corneal radius ratio for myopia assessment among Chinese children
by: Jingfeng Mu, et al.
Published: (2022-09-01)

Efficacy and safety of atropine to control childhood myopia progression
by: Martyna Lewkowicz, et al.
Published: (2022-06-01)

Hospital-prepared low-dose atropine eye drops for myopia progression control using atropine sulfate injection diluted in normal saline and lubricants
by: Nuthida Wongwirawat, et al.
Published: (2022-11-01)